Kunjin virus

Source: Wikipedia, the free encyclopedia.
Kunjin virus
Virus classification Edit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum: Kitrinoviricota
Class: Flasuviricetes
Order: Amarillovirales
Family: Flaviviridae
Genus: Flavivirus
Species:
West Nile virus
Serotype:
Kunjin virus
Ribbon diagram of Kunjin virus
Ribbon representation of the assembly of Kunjin virus from 60 sets of Envelope and Matrix proteins

Kunjin virus (KUNV) is a zoonotic virus of the family Flaviviridae and the genus Flavivirus. It is a subtype of West Nile virus endemic to Oceania.

History

The virus was first isolated from Culex annulirostris mosquitoes in Australia in 1960.[1][2] The name of Kunjin virus derives from an

Kowanyama, northern Queensland.[1][3]

Virology

Kunjin virus is a

antigenically and genetically very similar to West Nile virus and in 1999 was reclassified as a subtype of WNV.[3][5] Its genome is positive-sense single stranded RNA made up of 10,644 nucleotides.[3][4]

Symptoms and prognosis

Infection with the virus often causes no symptoms, but it can lead to either an

fatigue and rash.[1][6] Kunjin virus encephalitis features acute febrile meningoencephalitis.[1]

Both forms of Kunjin virus disease are milder than the diseases caused by West Nile virus and Murray Valley encephalitis virus.[5][6]

Transmission and control

Kunjin virus is transmitted by mosquito

South East Asia but in humans, only in Australia.[6] It has been found all over Australia and is particularly prevalent in areas near wetlands and rivers.[8]

The control of Kunjin virus is achieved in the same ways as other mosquito-borne diseases. These include individuals using insect repellent, wearing long-sleeved clothes and avoiding areas where mosquitoes are particularly prevalent.[1] Habitat control by government agencies can take the form of reducing the amount of water available for mosquitoes to breed in, and the use of insecticides.[9] There is no available vaccine against Kunjin virus.[1]

Use in medicine

In 2005, scientists at the

Queensland Institute of Medical Research and the University of Queensland found that modified Kunjin virus particles injected into mice were able to deliver a gene into the immune system targeting cancer cells.[10][11] This research may lead to vaccines for cancer and HIV.[10][11]

References

  1. ^
    Government of Australia. 2004-05-25. Archived from the original
    on 2009-10-30. Retrieved 2009-08-08.
  2. ISBN 978-1-55581-236-2
    .
  3. ^
    ISBN 978-0-85199-473-4
    .
  4. ^
    ISBN 978-0-8138-0379-1
    .
  5. ^ a b Bhattacharya, Shaoni (2003-08-12). "West Nile virus's milder cousin gives vaccine hope". New Scientist. Retrieved 2009-08-08.
  6. ^
    ISBN 978-1-4160-4470-3
    .
  7. ^ Scherret, Jacqueline H.; Michael Poidinger (Jul–Aug 2001). "The Relationships between West Nile and Kunjin Viruses". Centers for Disease Control and Prevention. Retrieved 2009-08-08.
  8. ^ Adlam, Nigel (2008-03-20). "Heavy rains bring mozzie diseases". Northern Territory News. Archived from the original on 2012-03-05. Retrieved 2009-08-08.
  9. ^ Russell, Richard C.; Stephen L. Doggett. "Murray Valley Encephalitis virus & Kunjin virus". University of Sydney—Department of Medical Entomology. Archived from the original on 2009-07-26. Retrieved 2009-08-08.
  10. ^ a b "Australian virus may lead to cancer vaccine". Australian Broadcasting Corporation. 2005-03-31. Retrieved 2009-08-08.
  11. ^ a b "New medical uses for the Kunjin virus". News-Medical.Net. 2005-04-12. Retrieved 2009-08-08.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Kunjin_virus&oldid=1157036090"